机构:[1]Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong, China[2]Department of Chemical Pathology, The Chinese University of Hong Kong, Hong Kong, China[3]Department of Nephrology, First People’s Hospital of Yunnan Province, Yunnan, China内科片肾内科云南省第一人民医院[4]Shenzhen Research Institute, CUHK, Shenzhen, China[5]Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China
The TGF-beta/Smad3 pathway plays a major role in tissue fibrosis, but the precise mechanisms are not fully understood. Here we identified microRNA miR-433 as an important component of TGF-beta/Smad3-driven renal fibrosis. The miR-433 was upregulated following unilateral ureteral obstruction, a model of aggressive renal fibrosis. In vitro, overexpression of miR-433 enhanced TGF-beta 1-induced fibrosis, whereas knockdown of miR-433 suppressed this response. Furthermore, Smad3, but not Smad2, bound to the miR-433 promoter to induce its expression. Delivery of an miR-433 knockdown plasmid to the kidney by ultrasound microbubble-mediated gene transfer suppressed the induction and progression of fibrosis in the obstruction model. The antizyme inhibitor Azin1, an important regulator of polyamine synthesis, was identified as a target of miR-433. Overexpression of miR-433 suppressed Azin1 expression, while, in turn, Azin1 overexpression suppressed TGF-beta signaling and the fibrotic response. Thus, miR-433 is an important component of TGF-beta/Smad3-induced renal fibrosis through the induction of a positive feedback loop to amplify TGF-beta/Smad3 signaling, and may be a potential therapeutic target in tissue fibrosis.
基金:
Research Grant Council of Hong KongHong Kong Research Grants Council [RGC GRF 468711, 469110, 768409, CUHK5/CRF/09, CUHK3/CRF/12R, GRF 463612, 464010, 763908, 764109]; Chinese University of Hong KongChinese University of Hong Kong [2010.2.025, 2011.1.076, 2012.1.021]; Hong Kong Society of Nephrology [6903213]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China [81170681]; Municipal Science and Technology R&D funding of basic research, Shenzhen [JC201104220290A]; Major State Basic Research Development Program of China (973 program)National Basic Research Program of China [2012CB517700]
第一作者机构:[1]Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong, China[2]Department of Chemical Pathology, The Chinese University of Hong Kong, Hong Kong, China[3]Department of Nephrology, First People’s Hospital of Yunnan Province, Yunnan, China
共同第一作者:
通讯作者:
通讯机构:[1]Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong, China[4]Shenzhen Research Institute, CUHK, Shenzhen, China[*1]Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong, China.
推荐引用方式(GB/T 7714):
Li Rong,Chung Arthur C. K.,Dong Yuan,et al.The microRNA miR-433 promotes renal fibrosis by amplifying the TGF-beta/Smad3-Azin1 pathway[J].KIDNEY INTERNATIONAL.2013,84(6):1129-1144.doi:10.1038/ki.2013.272.
APA:
Li, Rong,Chung, Arthur C. K.,Dong, Yuan,Yang, Weiqin,Zhong, Xiang&Lan, Hui Y..(2013).The microRNA miR-433 promotes renal fibrosis by amplifying the TGF-beta/Smad3-Azin1 pathway.KIDNEY INTERNATIONAL,84,(6)
MLA:
Li, Rong,et al."The microRNA miR-433 promotes renal fibrosis by amplifying the TGF-beta/Smad3-Azin1 pathway".KIDNEY INTERNATIONAL 84..6(2013):1129-1144